China and the United States are the leading exporters of 1-(2-Hydroxyethyl)piperazine, accounting for the largest share of global shipments, while Germany, India, and South Korea represent the top importing countries. Trade volumes have remained relatively stable, with modest growth observed in Asian and European procurement activity. Recent data indicates steady demand from pharmaceutical and agrochemical intermediates sectors, contributing to moderate upward pressure on 1-(2-Hydroxyethyl)piperazine prices amid consistent export flows from major producers.
Recent Market Dynamics Intelligence
1. **Price Trends**
- Over the past week, the domestic market price of N-ethylpiperazine (N-EP) has shown a slight upward fluctuation. The average market price in major regions rose from XX yuan/ton at the beginning of last week to XX yuan/ton at the beginning of this week, representing an increase of approximately X%.
- Prices vary across different product specifications. The price increase for industrial-grade products was relatively modest, at around X%. In contrast, pharmaceutical-grade products, which require higher quality standards and involve more complex production processes, saw a price increase of X%, with the current average price standing at XX yuan/ton.
2. **Supply Situation**
- The operating rates of major domestic producers remained generally stable, maintained between X% and X%. Although some enterprises experienced slight production declines due to equipment maintenance, overall supply did not exhibit significant fluctuations.
- On the import front, the volume of arriving cargo has decreased recently. This is primarily attributed to rising international shipping costs and production plan adjustments by certain overseas manufacturers, resulting in relatively tight availability of importable goods in the market.
3. **Demand Situation**
- Downstream industry demand has shown divergence. In the pharmaceutical sector, demand for N-ethylpiperazine as an intermediate has increased as some new drug R&D projects have entered clinical stages, leading some pharmaceutical companies to boost their procurement volumes.
- In the chemical sector, demand from polyurethane and epoxy resin manufacturers has remained steadily growing, driven by good order conditions. However, some small-scale chemical enterprises have faced production restrictions due to environmental policies, resulting in a decrease in raw material demand.
4. **Inventory Levels**
- Producer inventories are at moderate levels, with an average inventory turnover period of X to X days. Due to the recent increase in demand, some companies have seen faster inventory depletion and have expressed intentions to replenish stocks.
- Trader inventories are generally low. Some traders, holding positive expectations for future price trends, have exhibited a reluctance to sell, further reducing the supply of goods circulating in the market.
Analysis and Judgment
1. **Reasons for Price Increases**
- Supply Side: The reduction in imported goods and slight production declines among some domestic enterprises have led to a contraction in overall market supply, providing support for prices.
- Demand Side: Increased demand in the pharmaceutical and certain chemical sectors, particularly driven by new drug R&D in the pharmaceutical industry, has tightened the supply-demand balance, pushing prices up.
- Cost Factors: Recent increases in the prices of key raw materials have transferred cost pressure to the N-ethylpiperazine market, prompting producers to raise prices.
2. **Potential Market Risks**
- Uncertainty in Downstream Demand: Although current demand in the pharmaceutical and certain chemical sectors is robust, if future new drug R&D progress falls short of expectations or if chemical enterprises further reduce production due to environmental factors, demand could decline, exerting downward pressure on prices.
- Potential Changes in Import Supply: If international shipping costs decrease or overseas manufacturers resume production, an increase in imported goods could alleviate the tight supply situation and suppress price increases.
Forecast
1. **Short Term (1-2 Weeks)**
- Prices are expected to continue a slight upward trend. Given the currently tight supply-demand relationship, low producer inventories, and strong trader reluctance to sell, market prices are likely to rise by another X% to X% from current levels.
2. **Medium Term (1-2 Months)**
- If downstream demand in the pharmaceutical and chemical sectors continues to grow steadily and there is no significant increase in imported goods, prices will likely remain at high levels, with potential for further increases. However, if downstream demand fluctuates or a large influx of imported goods occurs, prices may experience a pullback.
3. **Long Term (3-6 Months)**
- Price trends will depend on long-term changes in supply and demand. With the advancement of new drug R&D and capacity adjustments in the chemical industry, if demand continues to grow while supply does not increase significantly, prices are expected to maintain an upward trend. Conversely, if supply becomes excessive or demand drops sharply, prices will face significant downward pressure.
1-(2-Hydroxyethyl)piperazine is a colorless to pale yellow, hygroscopic liquid with a mild amine-like odor; it has a melting point of approximately 10–12 °C and a boiling point of 279–281 °C at atmospheric pressure. It is classified as a heterocyclic organic compound and a functionalized piperazine derivative, featuring both a secondary amine and a primary alcohol group. Primarily used as a versatile chemical intermediate, it serves in the synthesis of pharmaceuticals (e.g., antihistamines and antimicrobials), agrochemicals (including fungicides and plant growth regulators), and specialty polymers. Its bifunctional reactivity also supports applications in corrosion inhibitors, chelating agents, and crosslinkers for coatings and epoxy resins.
1-(2-Hydroxyethyl)piperazine is a hydroxyalkyl substituted pieprazine used in the preparation of pharmaceutical compounds such as neuroleptic agents. 1-(2-Hydroxyethyl)piperazine Preparation Products And Raw materials Raw materials
clear colorless to pale yellow oily liquid
This chemical is included in Fine Chemicals. See more about what is 1-(2-Hydroxyethyl)piperazine and 1-(2-Hydroxyethyl)piperazine SDS information.
Find 1-(2-Hydroxyethyl)piperazine supply and 1-(2-Hydroxyethyl)piperazine suppliers on Guidechem to meet your sourcing needs from 263 trusted and certifedsuppliers.
Guidechem assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, fitness for purpose or timeliness.